Healthcare Data Analytics Solutions & Services

Healthcare industry leaders receive valuable insights, recommendations, and execution support from third-party analytics services. These services assist in making sound business decisions, crafting successful strategies, and implementing them effectively.

Healthcare Analytics Solutions

Data Analytics Solutions & Services for Healthcare Industry

The healthcare industry is currently undergoing significant changes that are reshaping how it operates and its overall business environment. The focus is shifting towards delivering value-ce­ntric healthcare approaches, with a growing influx of data and incre­ased access to patient and care­giver information. Furthermore, advances in technologies such as digitalization and robotic process automation are rapidly transforming daily operations within the industry. These developme­nts have profound implications for the sector’s business landscape.

Generative AI Development
Benefits of

SGA’s Healthcare Analytics Solutions

At SG Analytics (SGA), we provide comprehensive analytics solutions to gain valuable insights and make informed decisions for leading healthcare firms. Our team of skilled analysts conducts in-depth business research using a wide range of proprietary, public, and third-party sources. Additionally, our specialized teams in financial research, data analytics, engineering, and IT greatly contribute to our versatile capabilities. We are committed to assisting you in formulating or enhancing your go-to-market strategy, making market-entry decisions, acquiring competitive intelligence, conducting R&D initiatives, and predicting new product outcomes.

With a network of more than 700 influential experts across different regions, SGA accelerates client solutions by maximizing efficiency. For nearly two decades, SGA has been offering external research and analytics services to boost businesses in the healthcare sector, providing invaluable support to companies involved in products and services.

Healthcare Analytics Services & Solutions

Pe­rsonalized approaches are crucial for achie­ving success and thriving in today’s fast-pace­d, competitive landscape. Our tailored service­s in he­althcare market rese­arch and consulting offer customized rese­arch solutions, meticulous data handling and analysis, and comprehensive­ insights tailored to our industry partners’ specific ne­eds. From evaluating opportunities and asse­ssing priorities to gathering competitive­ intelligence, pe­rforming health economics and outcomes rese­arch (HEOR), providing conference cove­rage, understanding consumer insights, strate­gizing market entry plans, offering de­cision-making support, or conducting investment opportunity analysis in both establishe­d markets and emerging one­s – we have got you covere­d.

Learn More

In healthcare, SGA’s dedicated team specializes in research execution and monitoring, administrative and medical records, insurance records, vital records, follow-up, medical records, and peer-reviewed literature. These comprehensive data services serve global service providers and are presented in easily configurable, user-friendly dashboards and regular reports available daily, weekly, or monthly.

Learn More

Elevate your pharmaceutical and medtech endeavours with our specialized CRO services, focusing on biostatistics, clinical trial data management, medical writing, and clinical trial project management. Our dedicated team ensures the seamless execution of clinical trials, adhering to rigorous standards and accelerating the path to regulatory approval.

Learn More

Why SGA for Healthcare Analytics Solutions

Industry Leaders

SGA thrives by its brand promise Lifes Possible and is recognized as the trusted healthcare data analytics services & solutions provider company in the U.S.

12+ Languages

Multilingual capabilities include Mandarin, Cantonese, Korean, German, Spanish, Arabic, Bahasa, Hindi, Bengali, and English U.S. & U.K. experts either in-house or partnerships.

Data-Driven Insights

With in-depth domain knowledge and proven capabilities of delivering monetizable insights, we deliver high-quality, efficient outputs.

End-To-End Solutioning

The in-house KOL capability of more than 700, along with the in-house capabilities of primary market research, financial research, data analytics, data engineering, IT, and ESG research and consulting, helps to present credible competitive information.

Who We Work With

Life Sciences Consulting & Information Service Providers

We have run off-shored capability centers of ISPs and consulting companies, with a record of tracking >5,000 pharmaceutical companies, supporting their onshore teams to track markets, and helping them create actionable insights and recommendations.

Medical Devices

We support new product entries, competitive intelligence (CI), and market intelligence teams with relevant information.

Mergers and Acquisitions Analysis

We support clients with product portfolio fitment analysis, patents and clinical trial data, pipeline analysis, and shortlisting of healthcare acquirer and acquiree prospects.

In Vitro Diagnostics

We track diagnostics kits, reagents, and equipment, which help marketing and sales teams with market penetration efforts. Our services are preferred by product managers and marketing leaders.

Private Equity, Investment Banks, and Investor Community

We support financial firms with ad-hoc and white-labeled research comprising industry analysis, primary research, and CI from major markets.

Animal Health

We offer market intelligence on veterinary products and equipment and help mid-senior management with relevant data.

Pharmaceuticals & Biopharma

We support pharma and biopharma market intelligence, strategy, sales, marketing, and R&D teams in developed and developing markets.

Healthcare IT

We offer technology tracking services, market sizing and forecasting, and primary market research involving healthcare payers and providers and product launch information to healthcare IT leaders of the world.

Healthcare Ins(AI)ghts

Whitepaper

Healthcare Market Research in the Era of New Technology

As healthcare systems grow more complex, traditional research approaches face limitations in capturing real-time trends and patient behavior. This whitepaper explores how emerging technologies—like AI, machine learning, and synthetic data—are redefining healthcare market research. From improving predictive modeling to enhancing patient segmentation, these innovations are enabling faster, more accurate insights. Learn how forward-thinking healthcare organizations are modernizing their research frameworks to stay ahead of dynamic market shifts and deliver value-driven outcomes in a tech-powered era.

Read More

BLOG

Healthcare Industry Trends to Watch Out for in 2025

The global healthcare industry is entering a transformative era in 2025, driven by innovation, strategic investments, and evolving market dynamics. The industry is poised for growth across key submarkets like HealthTech, MedTech, and Pharmatech. A Deloitte Center for Health Solutions survey reveals that nearly 60% of industry leaders have a positive outlook for 2025, up from 52% the previous year. According to Bain & Company, the global healthcare private equity (PE) deal activity reached an estimated $115 billion in 2024, marking the second-highest deal value on record, driven by a surge in large-scale deals.

Read More

BLOG

HTA Approval and Market Trends in Europe

Health Technology Assessment (HTA) plays a vital role in determining patient access and reimbursement across European markets. With the HTA Regulation (EU 2021/2282) set to take effect in 2025, pharmaceutical companies must align their market access strategies accordingly. Agencies like France’s HAS, Germany’s GBA, and Scotland’s SMC assess the clinical and cost-effectiveness of new therapies, shaping national reimbursement decisions. Navigating this landscape requires submitting robust clinical and economic evidence through the HTA IT platform.

Read More
Our combined experience of pharmaceuticals, medical devices, life sciences, and med-tech ensures high-quality, white-labeled research coverage.
Let's Talk